{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:43:40Z","timestamp":1786981420937,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11046-025-01032-7","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T07:14:44Z","timestamp":1765869284000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Therapeutic Drug Monitoring of Itraconazole in Endemic Paracoccidioidomycosis: Real-World Data"],"prefix":"10.1007","volume":"191","author":[{"given":"Wdson Luis Lima","family":"Kruschewsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera Lucia Teixeira","family":"de Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariane","family":"Taborda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela Antonini Alves Oliveira","family":"Quadros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f4nica Scarpelli Martinelli","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago Alexandre","family":"Cocio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Benard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilo Jos\u00e9 Co\u00ealho","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edtor Falc\u00e3o","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Satie Gon\u00e7alves Kono","family":"Magri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello Mihailenko Chaves","family":"Magri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"issue":"5","key":"1032_CR1","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1590\/0037-8682-0230-2017","volume":"50","author":"MA Shikanai-Yasuda","year":"2017","unstructured":"Shikanai-Yasuda MA, Mendes RP, Colombo AL, et al. Brazilian guidelines for the clinical management of paracoccidioidomycosis. Rev Soc Bras Med Trop. 2017;50(5):715\u201340. https:\/\/doi.org\/10.1590\/0037-8682-0230-2017.","journal-title":"Rev Soc Bras Med Trop"},{"key":"1032_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1590\/0037-8682-0225-2013","volume":"47","author":"GD Vieira","year":"2014","unstructured":"Vieira GD, Alves TC, Lima SMD, et al. Paracoccidioidomycosis in a western Brazilian Amazon State: clinical-epidemiologic profile and spatial distribution of the disease. Rev Soc Bras Med Trop. 2014;47:63\u20138. https:\/\/doi.org\/10.1590\/0037-8682-0225-2013.","journal-title":"Rev Soc Bras Med Trop"},{"key":"1032_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/jof3010001","author":"R Martinez","year":"2017","unstructured":"Martinez R. New trends in paracoccidioidomycosis epidemiology. J Fungi. 2017. https:\/\/doi.org\/10.3390\/jof3010001.","journal-title":"J Fungi"},{"key":"1032_CR4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3109\/13693786.2012.714529","volume":"51","author":"F Bellissimo-Rodrigues","year":"2013","unstructured":"Bellissimo-Rodrigues F, Bollela VR, da Fonseca BAL, et al. Endemic paracoccidioidomycosis: relationship between clinical presentation and patients\u2019 demographic features. Med Mycol. 2013;51:313\u20138. https:\/\/doi.org\/10.3109\/13693786.2012.714529.","journal-title":"Med Mycol"},{"key":"1032_CR5","doi-asserted-by":"publisher","unstructured":"Borges SRC, Silva GMS da, Chambela M da C, et al. Itraconazole vs. trimethoprim-sulfamethoxazole: a comparative cohort study of 200 patients with paracoccidioidomycosis. Med Mycol. 2014;52(3):303\u2013310. https:\/\/doi.org\/10.1093\/mmy\/myt012","DOI":"10.1093\/mmy\/myt012"},{"key":"1032_CR6","doi-asserted-by":"publisher","unstructured":"Cavalcante R de S, Sylvestre TF, Levorato AD, et al. Comparison between itraconazole and cotrimoxazole in the treatment of paracoccidiodomycosis. PLoS Negl Trop Dis. 2014;8(4):e2793. https:\/\/doi.org\/10.1371\/journal.pntd.0002793","DOI":"10.1371\/journal.pntd.0002793"},{"issue":"10","key":"1032_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/jof8101098","volume":"8","author":"PM Pe\u00e7anha","year":"2022","unstructured":"Pe\u00e7anha PM, Pe\u00e7anha-Pietrobom PM, Gr\u00e3o-Velloso TR, et al. Paracoccidioidomycosis: what we know and what is new in epidemiology, diagnosis, and treatment. J Fungi. 2022;8(10):1098. https:\/\/doi.org\/10.3390\/jof8101098.","journal-title":"J Fungi"},{"issue":"4","key":"1032_CR8","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00233-21","volume":"35","author":"RC Hahn","year":"2022","unstructured":"Hahn RC, Hagen F, Mendes RP, et al. Paracoccidioidomycosis: current status and future trends. Clin Microbiol Rev. 2022;35(4):e0023321. https:\/\/doi.org\/10.1128\/cmr.00233-21.","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"1032_CR9","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/j.1875-9114.1996.tb02973.x","volume":"16","author":"VJ Van de Velde","year":"1996","unstructured":"Van de Velde VJ, Van Peer AP, Heykants JJ, et al. Effect of food on the pharmacokinetics of a new hydroxypropyl-beta-cyclodextrin formulation of itraconazole. Pharmacotherapy. 1996;16(3):424\u20138.","journal-title":"Pharmacotherapy"},{"issue":"3","key":"1032_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1046\/j.1365-2710.2001.00338.x","volume":"26","author":"L Willems","year":"2001","unstructured":"Willems L, van der Geest R, de Beule K. Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics. J Clin Pharm Ther. 2001;26(3):159\u201369. https:\/\/doi.org\/10.1046\/j.1365-2710.2001.00338.x.","journal-title":"J Clin Pharm Ther"},{"issue":"Suppl 1","key":"1032_CR11","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","volume":"24","author":"AJ Ullmann","year":"2018","unstructured":"Ullmann AJ, Aguado JM, Arikan-Akdagli S, et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect. 2018;24(Suppl 1):e1\u201338. https:\/\/doi.org\/10.1016\/j.cmi.2018.01.002.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"1032_CR12","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/jac\/dkt508","volume":"69","author":"HR Ashbee","year":"2014","unstructured":"Ashbee HR, Barnes RA, Johnson EM, et al. Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology. J Antimicrob Chemother. 2014;69(5):1162\u201376. https:\/\/doi.org\/10.1093\/jac\/dkt508.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"1032_CR13","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1-50. https:\/\/doi.org\/10.1093\/cid\/civ933.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"1032_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/myc.70096","volume":"68","author":"WLL Kruschewsky","year":"2025","unstructured":"Kruschewsky WLL, Costa ARH, Taborda M, et al. Serological response and associated prognostic factors in paracoccidioidomycosis: a 15-year retrospective study. Mycoses. 2025;68(7):e70096. https:\/\/doi.org\/10.1111\/myc.70096.","journal-title":"Mycoses"},{"key":"1032_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1590\/S0100-39842011000100008","volume":"44","author":"CS Moraes","year":"2011","unstructured":"Moraes CS, Queiroz-Telles F, Marchiori E, et al. Review of lung radiographic findings during treatment of patients with chronic paracoccidioidomycosis. Radiol Bras. 2011;44:20\u20138.","journal-title":"Radiol Bras"},{"key":"1032_CR16","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1086\/377538","volume":"37","author":"AM Tobon","year":"2003","unstructured":"Tobon AM, Agudelo CA, Osorio ML, et al. Residual pulmonary abnormalities in adult patients with chronic paracoccidioidomycosis: prolonged follow-up after itraconazole therapy. Clin Infect Dis. 2003;37:898\u2013904. https:\/\/doi.org\/10.1086\/377538.","journal-title":"Clin Infect Dis"},{"key":"1032_CR17","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1128\/AAC.37.4.778","volume":"37","author":"JA Barone","year":"1993","unstructured":"Barone JA, Koh JG, Bierman RH, et al. Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers. Antimicrob Agents Chemother. 1993;37:778\u201384. https:\/\/doi.org\/10.1128\/AAC.37.4.778.","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"1032_CR18","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00134-21","volume":"65","author":"AM Rauseo","year":"2021","unstructured":"Rauseo AM, Mazi P, Lewis P, et al. Bioavailability of single-dose SUBA-itraconazole compared to conventional itraconazole under fasted and fed conditions. Antimicrob Agents Chemother. 2021;65(8):e0013421. https:\/\/doi.org\/10.1128\/AAC.00134-21.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"1032_CR19","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s11046-023-00781-7","volume":"188","author":"VF de Oliveira","year":"2023","unstructured":"de Oliveira VF, Taborda M, Arcieri VC, et al. Itraconazole serum trough concentrations using oral capsules for the treatment of chronic pulmonary aspergillosis: what is the target? Mycopathologia. 2023;188(5):693\u20138. https:\/\/doi.org\/10.1007\/s11046-023-00781-7.","journal-title":"Mycopathologia"},{"issue":"1","key":"1032_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1128\/AAC.00705-08","volume":"53","author":"D Andes","year":"2009","unstructured":"Andes D, Pascual A, Marchetti O. Antifungal therapeutic drug monitoring: established and emerging indications. Antimicrob Agents Chemother. 2009;53(1):24\u201334. https:\/\/doi.org\/10.1128\/AAC.00705-08.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"1032_CR21","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw326","volume":"63","author":"TF Patterson","year":"2016","unstructured":"Patterson TF, Thompson GR, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63(4):e1\u201360. https:\/\/doi.org\/10.1093\/cid\/ciw326.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"1032_CR22","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.1093\/cid\/ciw360","volume":"63","author":"JN Galgiani","year":"2016","unstructured":"Galgiani JN, Ampel NM, Blair JE, et al. 2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis. Clin Infect Dis. 2016;63(6):e112\u201346. https:\/\/doi.org\/10.1093\/cid\/ciw360.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"1032_CR23","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1086\/521259","volume":"45","author":"LJ Wheat","year":"2007","unstructured":"Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45(7):807\u201325. https:\/\/doi.org\/10.1086\/521259.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1032_CR24","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1086\/649858","volume":"50","author":"JR Perfect","year":"2010","unstructured":"Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(3):291\u2013322. https:\/\/doi.org\/10.1086\/649858.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"1032_CR25","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1086\/588300","volume":"46","author":"SW Chapman","year":"2008","unstructured":"Chapman SW, Dismukes WE, Proia LA, et al. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis. 2008;46(12):1801\u201312. https:\/\/doi.org\/10.1086\/588300.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"1032_CR26","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/j.1348-0421.2006.tb03840.x","volume":"50","author":"K Uchida","year":"2006","unstructured":"Uchida K, Abe S, Yamaguchi H. The postantifungal effect (PAFE) of itraconazole, in comparison with those of miconazole and fluconazole, on Candida Species. Microbiol Immunol. 2006;50(9):679\u201385. https:\/\/doi.org\/10.1111\/j.1348-0421.2006.tb03840.x.","journal-title":"Microbiol Immunol"},{"issue":"Suppl 7","key":"1032_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1469-0691.2006.01611.x","volume":"12","author":"ADG Hurl\u00e9","year":"2006","unstructured":"Hurl\u00e9 ADG, Navarro AS, S\u00e1nchez MJG. Therapeutic drug monitoring of itraconazole and the relevance of pharmacokinetic interactions. Clin Microbiol Infect. 2006;12(Suppl 7):97\u2013106. https:\/\/doi.org\/10.1111\/j.1469-0691.2006.01611.x.","journal-title":"Clin Microbiol Infect"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-025-01032-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-025-01032-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-025-01032-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:53:18Z","timestamp":1771055598000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-025-01032-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1032"],"URL":"https:\/\/doi.org\/10.1007\/s11046-025-01032-7","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"5"}}